All News

(photo by Erin O. Smith)

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

An initiative at VUMC is helping patients recover more quickly from major surgery, leave the hospital earlier and have fewer side effects from their pain management. (photo by Joe Howell)

Ketamine fails surgical recovery trial

In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery.

(iStock)

Women who receive mammograms also undergo lung scans if notified of eligibility

Study showed that the improvement in lung cancer screenings exceeded the target enrollment set by the researchers.

Study seeks to determine best way to treat myopia in children

Researchers hope to slow the progression of this chronic eye disease that affects approximately 40% of the U.S. population.

Timothy Sterling receives $5.7 million to study tuberculosis transmission

Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.

1 2 3 142